Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bellicum Pharma Comm (BLCM)

3.77   -0.08 (-2.08%) 03-05 09:14
Open: 4.03 Pre. Close: 3.85
High: 4.45 Low: 3.51
Volume: 1,187,589 Market Cap: 23M
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. It has collaboration and license agreements with Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Houston, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.455 - 4.491 4.491 - 4.516
Low: 3.449 - 3.482 3.482 - 3.503
Close: 3.725 - 3.778 3.778 - 3.814

Technical analysis

as of: 2021-03-05 8:43:23 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 7.45     One year: 9.52
Support: Support1: 3.51    Support2: 2.92
Resistance: Resistance1: 6.38    Resistance2: 8.15
Pivot: 5.16
Moving Average: MA(5): 4.11     MA(20): 5.06
MA(100): 4.19     MA(250): 5.61
MACD: MACD(12,26): -0.11     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 2.76     %D(3): 3.49
RSI: RSI(14): 38.41
52-week: High: 9.56  Low: 2.62  Change(%): -53.6
Average Vol(K): 3-Month: 93684  10-Days: 54918

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BLCM has closed above bottom band by 16.4%. Bollinger Bands are 110.8% wider than normal. The large width of the bands suggest high volatility as compared to BLCM's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
Bellicum Pharmaceuticals Inc (BLCM) Stock Loses -16.11% This Week; Should You Buy? - InvestorsObserver

Thu, 04 Mar 2021
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Wed, 03 Mar 2021
Bellicum Pharmaceuticals Inc. (BLCM) Plunges 7.67% on March 03 -

Thu, 25 Feb 2021
Bellicum Pharmaceuticals Inc. (BLCM) Plunges 8.02% on February 25 -

Fri, 19 Feb 2021
Is Bellicum Pharmaceuticals Inc (BLCM) Stock a Smart Value? - InvestorsObserver

Thu, 18 Feb 2021
Bellicum Pharmaceuticals Inc. (BLCM) Plunges 8.05% on February 18 -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 6
Shares Float (M) 5
% Held by Insiders 0.32
% Held by Institutions 23.90
Shares Short (K) 162
Shares Short P. Month (K) 293

Stock Financials

EPS -11.022
EPS Est This Year -3.020
EPS Est Next Year -2.950
Book Value (p.s.) -9.490
Profit Margin
Operating Margin -1057.41
Return on Assets (ttm) -34.9
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -9.070
Sales Per Share 0.841
EBITDA (p.s.) -8.418
Qtrly Earnings Growth
Operating Cash Flow (M) -56
Levered Free Cash Flow (M) -35

Stock Valuations

PE Ratio -0.34
PEG Ratio
Price to Book value -0.40
Price to Sales 4.48
Price to Cash Flow -0.41

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.